ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $106K invested in Enlivex Therapeutics in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$16.4K

Top Sellers

1
-$25K
2
-$17K
3
-$9K
4
OC
Oppenheimer & Co
New York
-$8K
5
UBS Group
UBS Group
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$106K
2
–
3
–
4
–
5
–
6
–